Olanzapine-induced reversible pellagroid skin lesion: A case report

Lokesh K. Singh, Manoj Sahu, Samir K. Praharaj

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Adverse cutaneous reactions are frequently reported to occur with the use of psychotropic medications, which may lead to poor drug compliance. As compared to other groups of psychotropic medication, antipsychotics, both typical and atypical, are less likely to cause adverse cutaneous reactions. The most frequent cutaneous adverse reactions associated with antipsychotics include fixed drug eruptions, exanthematous eruptions, photosensitivity reactions and altered skin pigmentation. Most of these commonly seen cutaneous adverse reactions are benign and easily treatable. Rarely, severe cutaneous adverse reactions such as erythema multiforme, Steven-Johnson syndrome are toxic epidermal necrolysis and have also been associated with antipsychotics. Olanzapine is one of the most commonly prescribed atypical antipsychotic with metabolic complications as most common adverse effects. Dermatological reactions are rarely observed with olanzapine. We report occurrence of pellagroid skin lesions over exposed areas of upper limbs with olanzapine that resolved completely after its discontinuation.

Original languageEnglish
Pages (from-to)251-253
Number of pages3
JournalCurrent Drug Safety
Volume10
Issue number3
Publication statusPublished - 01-01-2015

All Science Journal Classification (ASJC) codes

  • Toxicology
  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Olanzapine-induced reversible pellagroid skin lesion: A case report'. Together they form a unique fingerprint.

  • Cite this